|
|
CROSCARMELLOSE SODIUM Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
COTTONSEED OIL Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
DIBUTYL SEBACATE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
DIFICID Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|